Non-classical estrogen signaling in ovarian cancer improves chemo-sensitivity and patients outcome
Conclusion: These findings characterize a novel role of ERα in mediating the molecular connection between hormone and HRR in EOC and encourage hormone replacement therapy for EOC patients.
Source: Theranostics - Category: Molecular Biology Authors: Dapeng Hao, Jingjing Li, Jianlin Wang, Yuan Meng, Zhiqiang Zhao, Chao Zhang, Kai Miao, Chuxia Deng, Benjamin K. Tsang, Li Wang, Li-jun Di Tags: Research Paper Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Epithelial Cancer | Gastroschisis Repair | Genetics | Hormone Replacement Therapy | Hormones | Men | Molecular Biology | Ovarian Cancer | Ovaries